BioVie Inc (BIVI) Stock Price, Quote, News & History

BIVINASDAQ
$2.24
-0.04-1.75%
At close: Aug 31, 5:00 PM EST
$2.23
-0.0487-2.14%
Pre-Market: 8:07 AM EST
Loading...

Key Statistics

Open
-
Close
$2.24
Volume / Avg.
16.81K / 4.47M
Day Range
- - -
52 Wk Range
0.82 - 3.79
Market Cap
$18.86M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
61
Short Interest
14.91%
Days to Cover
1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-19.02M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
10.46M
Free Cash Flow (TTM)
-19.02M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-8.57M

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$10.31M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.85
Earnings Yield % (TTM)
-135.56%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.22

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$8.98M
Debt to Equity
0.03
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
$0

Key Statistics

Open
-
Close
$2.24
Volume / Avg.
16.81K / 4.47M
Day Range
- - -
52 Wk Range
0.82 - 3.79
Market Cap
$18.86M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
61
Short Interest
14.91%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
BioVie Inc is a clinical-stage company developing drug therapies for the treatment of neurological and neurodegenerative disorders and liver disease. Its therapeutic areas include Alzheimer's, Parkinson's, Long COVID, Ascites, Longevity, and Epigenet...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy BioVie (BIVI) stock?

A

You can purchase shares of BioVie (NASDAQ:BIVI) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for BioVie (BIVI) stock?

A

BioVie has a consensus price target of $4.00.

Q

What is the current price for BioVie (BIVI)?

A

The stock price for BioVie (NASDAQ: BIVI) is $2.2313 last updated September 2, 2026 at 8:42 AM EDT.

Q

Does BioVie (BIVI) pay a dividend?

A

There are no upcoming dividends for BioVie.

Q

When is BioVie (NASDAQ:BIVI) reporting earnings?

A

BioVie does not have any upcoming earnings scheduled.

Q

Is BioVie (BIVI) going to split?

A

There is no upcoming split for BioVie.

Q

What sector and industry does BioVie (BIVI) operate in?

A

BioVie is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.